Lung Cancer 2008, 60:40–6.Talazoparib cost PubMedCrossRef 71. Gallegos-Arreola MP,

Figuera-Villanueva LE, Troyo-Sanroman R, Morgán-Villela G, Puebla-Pérez AM, Flores-Marquez MR, Zúniga-González GM: CYP1A1 *2B and *4 polymorphisms are associated with lung cancer susceptibility in Mexican patients. Int J Biol Markers 2008, 23:24–30.PubMed 72. Shah PP, Singh AP, Singh M, Mathur N, Pant MC, Mishra BN, Parmar D: Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer. Mutat Res 2008, 639:1–10.PubMedCrossRef 73. Kumar M, Agarwal SK, Goel SK: Lung cancer risk in north Indian population: role of genetic polymorphisms and smoking. Mol Cell Biochem 2009, 322:73–9.PubMedCrossRef 74. Cote ML, Yoo W, Wenzlaff VS-4718 supplier AS, Prysak GM, Santer SK, Claeys GB, Van Dyke AL, Land SJ, Schwartz AG: Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. check details Carcinogenesis 2009, 30:626–635.PubMedCrossRef 75. Honma HN, De Capitani EM, Barbeiro Ade S, Costa DB, Morcillo A, Zambon L: Polymorphism of the CYP1A1*2A gene and susceptibility to lung cancer in a Brazilian population. J Bras Pneumol 2009, 35:767–772.PubMedCrossRef 76. Klinchid J, Chewaskulyoung B, Saeteng S, Lertprasertsuke N, Kasinrerk

W, Cressey R: Effect of combined genetic polymorphisms on lung cancer risk in northern Thai women. Cancer Genet Cytogenet 2009, 195:143–149.PubMedCrossRef 77. Timofeeva MN, Kropp S, Sauter W, Beckmann L, Rosenberger A, Illig T, Jäger B, Mittelstrass K, Dienemann H, Bartsch H, Bickeböller H, Chang-Claude JC, Risch A, Wichmann HE: CYP450

polymorphisms as risk factors for early-onset lung cancer: gender-specific differences. Carcinogenesis 2009, 30:1161–1169.PubMedCrossRef 78. Shaffi SM, Shah MA, Bhat IA, Koul P, Ahmad SN, Siddiqi MA: CYP1A1 polymorphisms and risk of lung cancer in the ethnic Kashmiri population. Asian Pac J Cancer Prev 2009, 10:651–656.PubMed 79. Jin Y, Xu H, Zhang C, Kong Y, Hou Y, Xu Y, Xue S: Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor Phosphoglycerate kinase genes on non small cell lung cancer:a hospital-based case-control study in China. BMC Cancer 2010, 10:422.PubMedCrossRef 80. Wright CM, Larsen JE, Colosimo ML, Barr JJ, Chen L, McLachlan RE, Yang IA, Bowman RV, Fong KM: Genetic association study of CYP1A1 polymorphisms identifies risk haplotypes in nonsmall cell lung cancer. Eur Respir J 2010, 35:152–159.PubMedCrossRef 81. Hirschhorn JN, Lohmueller K, Byrne E: A comprehensive reviewof genetic association studies. Genet Med 2002, 4:45–61.PubMedCrossRef 82. Sato S, Nakamura Y, Tsuchiya E: Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 1994, 54:5652–5.PubMed 83. Wydner EL, Hoffman D: Smoking and lung cancer: scientific challenges and opportunities. Cancer Res 1994, 54:5284–95. 84.